Renal Cancer - Results from #100

Long-term oncologic outcomes of laparoscopic renal cryoablation as primary treatment for small renal masses - Beyond the Abstract July 15, 2015

A phase II trial of dosage escalation of sorafenib in Asian patients with metastatic renal cell carcinoma, "Beyond the Abstract," by Ding-wei Ye June 12, 2015

Renal cell carcinoma subtype differentiation using single-phase corticomedullary contrast-enhanced CT, "Beyond the Abstract," by António P. Matos and Miguel Ramalho June 3, 2015

Saudi Oncology Society and Saudi Urology Association combined clinical management guidelines for renal cell carcinoma, "Beyond the Abstract," by Danny Monther Rabah May 8, 2015

Study finds no evidence to suggest that indeterminate pulmonary nodules of less than 1 cm are associated with renal cell carcinoma progression, "Beyond the Abstract," by Roy Mano and Paul Russo April 16, 2015

Unclassified mucinous renal cell carcinoma, "Beyond the Abstract," by Omer A. Raheem, MD, MSc Anat, MCh Urol, MRCS; Ahmed Shabaik, MD; and J. Kellogg Parsons, MD, MPH April 9, 2015

Kidney cancer risk in patients with kidney stones: Insights into the possible underlying pathophysiology, "Beyond the Abstract," by Charat Thongprayoon, MD and Wisit Cheungpasitporn, MD March 6, 2015

Novel use of AngioVac system to prevent pulmonary embolism during radical nephrectomy with inferior vena cava thrombectomy, "Beyond the Abstract," by Matthew A. Uhlman, MD, MBA March 6, 2015

A case report of early and prolonged response to pazopanib in a patient with multiple metastases from renal cell carcinoma, "Beyond the Abstract," by Elisa Biasco February 12, 2015

A systematic review of surgical series and United States population-level burden estimate of preoperatively misclassified, surgically-removed benign renal masses, "Beyond the Abstract," by David C. Johnson, MD, MPH February 6, 2015

Stage-dependent prognostic impact of molecular signatures in clear cell renal cell carcinoma, "Beyond the Abstract," by Thomas Weber, MD January 6, 2015

A European multi-institutional study of the prognostic significance of cytoreductive nephrectomy in patients with synchronous metastases from renal cell carcinoma treated with first-line sunitinib, "Beyond the Abstract," by Aristotle Bamias November 13, 2014

Exonic methylation of VHL in renal cell carcinoma, "Beyond the Abstract," by Fei Lian and John A. Petros November 11, 2014

Neoadjuvant sorafenib treatment of clear cell renal cell carcinoma and release of circulating tumor fragments, "Beyond the Abstract," by William Leenders, PhD, et al November 11, 2014

Ampullary tumor caused by metastatic renal cell carcinoma, "Beyond the Abstract," by Jiaobo Zhai, MD October 24, 2014

The CXCL7/CXCR1/2 axis is a key driver in the growth of clear cell renal cell carcinoma, "Beyond the Abstract," by Sandy Giuliano, Mélanie Guyot, Renaud Grepin, and Gilles Pages October 10, 2014

Efficacy of everolimus in patients with advanced renal cell carcinoma refractory or intolerant to VEGFR-TKIs and safety compared with prior VEGFR-TKI treatment, "Beyond the Abstract," by Renpei Kato, MD August 26, 2014

Two successful cases of the treatment of transitional cell carcinoma involving the renal pelvis in either a functional or anatomical solitary kidney, "Beyond the Abstract," by Bo Yang August 7, 2014

Chemotherapy-mediated p53-dependent DNA damage response in clear cell renal cell carcinoma: Role of the mTORC1/2 and hypoxia-inducible factor pathways, "Beyond the Abstract," by Veronica A. Carroll, PhD July 25, 2014

Adequate immunosuppression and oncological control employing temsirolimus as a base immunosuppressant for a recipient with metastatic renal cancer, "Beyond the Abstract," by Shih-Chieh Jeff Chueh, MD, PhD July 24, 2014

Page 6 of 11